IMRT for Paranasal Sinus Tumors
Author Information
Author(s): Stephanie E Combs, Stephan Konkel, Daniela Schulz-Ertner, Marc W Münter, Jürgen Debus, Peter E Huber, Christoph Thilmann
Primary Institution: University of Heidelberg, Department of Radiation Oncology
Hypothesis
The study aims to evaluate the clinical outcome of intensity modulated radiotherapy (IMRT) in patients with paranasal sinus tumors, particularly regarding treatment-related toxicity.
Conclusion
IMRT for tumors of the paranasal sinuses is associated with very good tumor control rates and minimized treatment-related toxicity compared to conventional radiotherapy.
Supporting Evidence
- Overall survival rates were 96% at 1 year and 90% at 3 years.
- Local control rates were 85% at 1 year and 81% at 2 years after primary RT.
- Distant metastases-free survival was 83% after 1 year for patients treated with IMRT as primary RT.
Takeaway
Doctors used a special type of radiation treatment called IMRT on patients with nose tumors, and it worked really well without causing many side effects.
Methodology
The study treated 46 patients with histologically proven tumors of the paranasal sinuses using IMRT and followed them for clinical outcomes and toxicity.
Limitations
The study's findings may be limited by the small sample size and the retrospective nature of the analysis.
Participant Demographics
{"gender":{"female":18,"male":28},"histology":{"adenocarcinoma":12,"squamous_cell_carcinoma":6,"adenoidcystic_carcinoma":20,"melanoma":8}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website